Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1956 1
1960 1
1962 1
1963 9
1964 7
1965 7
1966 1
1969 3
1970 1
1971 4
1972 3
1973 4
1974 13
1975 28
1976 26
1977 42
1978 32
1979 31
1980 73
1981 103
1982 144
1983 162
1984 200
1985 224
1986 248
1987 217
1988 360
1989 453
1990 455
1991 515
1992 614
1993 622
1994 670
1995 784
1996 848
1997 866
1998 989
1999 1058
2000 1187
2001 1311
2002 1329
2003 1443
2004 1638
2005 1765
2006 1957
2007 2106
2008 2349
2009 2457
2010 2529
2011 2617
2012 2757
2013 2814
2014 3113
2015 3223
2016 3087
2017 3087
2018 3208
2019 3449
2020 3919
2021 4049
2022 3525
2023 3446
2024 3873
2025 3815
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71,753 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for tumor ag
Search for Tudor AG instead (2 results)
Pancreatic Cysts.
Gonda TA, Cahen DL, Farrell JJ. Gonda TA, et al. N Engl J Med. 2024 Sep 5;391(9):832-843. doi: 10.1056/NEJMra2309041. N Engl J Med. 2024. PMID: 39231345 Review. No abstract available.
Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
Cena H, Chiovato L, Nappi RE. Cena H, et al. J Clin Endocrinol Metab. 2020 Aug 1;105(8):e2695-709. doi: 10.1210/clinem/dgaa285. J Clin Endocrinol Metab. 2020. PMID: 32442310 Free PMC article. Review.
EVIDENCE ACQUISITION: The aim of the present narrative review is to describe the mechanisms responsible for the development of infertility and PCOS in women with obesity/overweight, with a focus on the emerging role of glucagon-like peptide-1 (GLP-1) receptor agonists (GLP …
EVIDENCE ACQUISITION: The aim of the present narrative review is to describe the mechanisms responsible for the development of infertility a …
Hirsutism in Women.
Matheson E, Bain J. Matheson E, et al. Am Fam Physician. 2019 Aug 1;100(3):168-175. Am Fam Physician. 2019. PMID: 31361105 Free article. Review.
Less common causes include idiopathic hirsutism, nonclassic congenital adrenal hyperplasia, androgen-secreting tumors, medications, hyperprolactinemia, thyroid disorders, and Cushing syndrome. Women with an abnormal hirsutism score based on the Ferriman-Gallwey scoring sys …
Less common causes include idiopathic hirsutism, nonclassic congenital adrenal hyperplasia, androgen-secreting tumors, medications, h …
GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons.
Papaetis GS, Kyriacou A. Papaetis GS, et al. Adv Clin Exp Med. 2022 Nov;31(11):1265-1274. doi: 10.17219/acem/151695. Adv Clin Exp Med. 2022. PMID: 35951627 Free article. Review.
Weight loss is of vital importance for overweight/obese individuals with anovulatory infertility. The GLP-1R agonists have achieved remarkable weight reduction and abdominal fat loss in patients with type 2 diabetes (T2D), as well as in overweight/obese individuals and ind …
Weight loss is of vital importance for overweight/obese individuals with anovulatory infertility. The GLP-1R agonists have achieved r …
Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD.
Mae SI, Hattanda F, Morita H, Nozaki A, Katagiri N, Ogawa H, Teranaka K, Nishimura Y, Kudoh A, Yamanaka S, Matsuse K, Ryosaka M, Watanabe A, Soga T, Nishio S, Osafune K. Mae SI, et al. Cell Rep. 2023 Dec 26;42(12):113431. doi: 10.1016/j.celrep.2023.113431. Epub 2023 Nov 30. Cell Rep. 2023. PMID: 38039961 Free article.
In autosomal dominant polycystic kidney disease (ADPKD), renal cyst lesions predominantly arise from collecting ducts (CDs). However, relevant CD cyst models using human cells are lacking. ...Therefore, our in vitro CD cyst model contributes to understanding …
In autosomal dominant polycystic kidney disease (ADPKD), renal cyst lesions predominantly arise from collecting ducts (CDs). However, …
The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.
Jensterle M, Janez A, Fliers E, DeVries JH, Vrtacnik-Bokal E, Siegelaar SE. Jensterle M, et al. Hum Reprod Update. 2019 Jul 1;25(4):504-517. doi: 10.1093/humupd/dmz019. Hum Reprod Update. 2019. PMID: 31260047 Review.
BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) have become firmly established in the treatment of type 2 diabetes and obesity, disorders frequently associated with diminished reproductive health. ...
BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) have become firmly established in the treatment of type 2 d …
GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis.
Han Y, Li Y, He B. Han Y, et al. Reprod Biomed Online. 2019 Aug;39(2):332-342. doi: 10.1016/j.rbmo.2019.04.017. Epub 2019 Apr 25. Reprod Biomed Online. 2019. PMID: 31229399
GLP-1 receptor agonists were associated with a higher incidence of nausea and headache than metformin, but there were no significant differences in other data. Therefore, compared with metformin, GLP-1 receptor agonists might be a good choice for obese patients with …
GLP-1 receptor agonists were associated with a higher incidence of nausea and headache than metformin, but there were no significant …
Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis.
Eberle A, Nguyen DB, Smith JP, Mansour FW, Krishnamurthy S, Zakhari A. Eberle A, et al. Obstet Gynecol. 2024 Jan 1;143(1):53-66. doi: 10.1097/AOG.0000000000005444. Epub 2023 Nov 9. Obstet Gynecol. 2024. PMID: 37944155
In the meta-analysis, dienogest showed significant reduction in cyst diameter (reduction 1.32 cm, 95% CI, 0.91-1.73, eight studies, n=418 cysts) and volume (mean difference of log-transformed volume 1.35, 95% CI, 0.87-1.83, seven studies, n=282 cysts). Simila …
In the meta-analysis, dienogest showed significant reduction in cyst diameter (reduction 1.32 cm, 95% CI, 0.91-1.73, eight studies, n …
Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy.
Sánchez-Garrido MA, Serrano-López V, Ruiz-Pino F, Vázquez MJ, Rodríguez-Martín A, Torres E, Velasco I, Rodríguez AB, Chicano-Gálvez E, Mora-Ortiz M, Ohlsson C, Poutanen M, Pinilla L, Gaytán F, Douros JD, Yang B, Müller TD, DiMarchi RD, Tschöp MH, Finan B, Tena-Sempere M. Sánchez-Garrido MA, et al. Nat Commun. 2024 Oct 1;15(1):8498. doi: 10.1038/s41467-024-52898-y. Nat Commun. 2024. PMID: 39353946 Free PMC article.
Our data illustrate the superior efficacy of GLP1/E vs. other multi-agonists and metformin in the management of metabolic complications of PCOS; GLP1/E ameliorates also ovarian cyclicity in an ovulatory model of PCOS, without direct estrogenic uterotrophic effects. ...Alto …
Our data illustrate the superior efficacy of GLP1/E vs. other multi-agonists and metformin in the management of metabolic complicatio …
71,753 results
You have reached the last available page of results. Please see the User Guide for more information.